Committed to Education
Raising public awareness of the potential of rejuvenation biotechnology.
For the first time in human history, we can consider bringing aging and age-related diseases under medical control to be a realistic goal. Emerging rejuvenation technologies could free us from aging and disease, providing our children and ourselves with a hundred years of healthy life, strength, and youthful appearance – and perhaps more.
It has been known that Google wants to defeat aging; back in 2013, it established Calico, a company devoted to this goal. Mark Zuckerberg and his wife plan to get rid of diseases, investing their Facebook money into medical research. In Germany, a political party devoted to health research advocates the allocation of 1% of Germany’s budget to the launch of a large project to solve human aging. Similar organizations exist in many countries. However, their investments and efforts are not enough.
It is necessary for people from all walks of life to unite in a single international initiative to achieve victory over age-related diseases. The first critical step on this path is to disseminate evidence-based knowledge about aging and rejuvenation among the general public, including the business sector and philanthropists. The goal is to attract more resources to aging research and ensure that rejuvenation therapies are developed as soon as possible. Public awareness of the potential of these technologies will also lead to more initiatives to improve governmental legislation regulating the development, registration, and equal access to innovative interventions that address the mechanisms of aging.
To achieve this goal, LEAF engages in a variety of educational activities. You can support us by becoming one of our Lifespan Heroes and making small, recurring donations: every dollar you give will help us reach out to more people.
LEAF Blog & Newsletter: Explaining rejuvenation science and related topics in plain language
The goal of this project is to increase public awareness of aging as a biological process that is amenable to medical intervention, such as by discussing therapies that address the main mechanisms of aging in order to prevent and cure age-related diseases.
We help people learn the basics of aging and its main mechanisms and inform them of the progress in bringing each of the Hallmarks of Aging under medical control, including animal studies and human clinical trials. Apart from gerontology, we look at demographic dynamics, population aging, and economic and social implications to help form a systemic vision of the problem of aging. In our articles, we also discuss the ethics of rejuvenation technologies, the scenarios of their future global implementation, and typical concerns related to longer lives.
Even More News
- Recently, we had the opportunity to interview Rick Kiessig, the co-founder of Kimer Med, a company developing a ...
- In this interview at Ending Age-Related Diseases 2020, Elena Milova of Lifespan.io and Daria Khaltourina of the ...Posted in: News
LEAF Events: Running live events to close the gap between researchers and the public
The goal of this project is to provide the community with more exciting opportunities to interact with aging and longevity researchers as well as popular life extension advocates and medical specialists who use currently available anti-aging technologies in clinical practice.
At these events, we discuss various topics related to the development of rejuvenation biotechnologies, including the latest findings, regulatory issues, the public perception of the idea of living longer in good health, and the most common public concerns, such as equal access to medical innovations and ethics.
The recordings of our live events are valuable educational materials. We edit them, release them on our Youtube channel and Facebook page, and engage our social media network so that more people get the chance to watch them.
LEAF Talks: attending scientific and public conferences
There are two main goals of this activity. First, we give talks at public events, disseminating among the general public up-to-date results of rejuvenation research as well as our views on related aspects of the issue, such as demographic trends; the individual, social and economic benefits of implementing rejuvenation technologies into clinical practice; and how to improve the regulatory landscape to better ensure equal access to these innovative therapies.
Second, we also use this as an opportunity to build a strong network of longevity-friendly organizations and individual activists, allowing us to unite efforts for big endeavors. For instance, last year, our team joined forces with the Global Healthspan Policy Institute to promote Nir Barzilai’s project TAME, a clinical trial to test metformin in healthy people to see if it increases healthy lifespan.
However, our work at the conferences is not reduced to giving talks to the general public and networking. LEAF members share their knowledge and experience in advocacy with our colleagues from other organizations as well as individual activists, discussing the different aspects of effective communication with the general public, fundraising for science, and advocacy.
Conferences are also a great place to provide the community with even more informative content. There, we bring the community exclusive interviews with the leading researchers in rejuvenation biotechnology, discuss their achievements and plans, and bring you the very latest news from this exciting field.